95 related articles for article (PubMed ID: 12818024)
21. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
Banks E; Canfell K
Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
[TBL] [Abstract][Full Text] [Related]
22. Effects of menopause and estrogen replacement therapy or hormone replacement therapy in women with diabetes mellitus: consensus opinion of The North American Menopause Society.
Menopause; 2000; 7(2):87-95. PubMed ID: 10746890
[TBL] [Abstract][Full Text] [Related]
23. Myocardial blood flow and flow reserve in response to short-term cyclical hormone replacement therapy in postmenopausal women.
Duvernoy CS; Rattenhuber J; Seifert-Klauss V; Bengel F; Meyer C; Schwaiger M
J Gend Specif Med; 2001; 4(3):21-7, 47. PubMed ID: 11605352
[TBL] [Abstract][Full Text] [Related]
24. Hormone replacement therapy in endometrial cancer survivors: new perspectives after the heart and estrogen progestin replacement study and the women's health initiative.
McDonnell BA; Twiggs LB
J Low Genit Tract Dis; 2006 Apr; 10(2):92-101. PubMed ID: 16633238
[TBL] [Abstract][Full Text] [Related]
25. Achieving long-term continuance of menopausal ERT/HRT: consensus opinion of the North American Menopause Society.
Menopause; 1998; 5(2):69-76. PubMed ID: 9689198
[TBL] [Abstract][Full Text] [Related]
26. [What's new in hormone replacement therapy of postmenopausal women? II. Risks of hormone replacement therapy (HRT)].
Martin-Du Pan RC; Luzuy F
Rev Med Suisse Romande; 2000 Jun; 120(6):523-7. PubMed ID: 11014097
[TBL] [Abstract][Full Text] [Related]
27. [Postmenopausal hormone substitution--for many of for few? I. Effects of long-term hormone substitution].
Berntsen GK; Tollan A; Fønnebø V
Nord Med; 1997 Oct; 112(8):276-9. PubMed ID: 9411395
[TBL] [Abstract][Full Text] [Related]
28. Risk of venous thromboembolism in users of hormone replacement therapy.
Daly E; Vessey MP; Hawkins MM; Carson JL; Gough P; Marsh S
Lancet; 1996 Oct; 348(9033):977-80. PubMed ID: 8855852
[TBL] [Abstract][Full Text] [Related]
29. Hormone replacement therapy in postmenopausal women with diabetes mellitus: a risk-benefit assessment.
Andersson B
Drugs Aging; 2000 Nov; 17(5):399-410. PubMed ID: 11190419
[TBL] [Abstract][Full Text] [Related]
30. A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy.
Douketis JD; Ginsberg JS; Holbrook A; Crowther M; Duku EK; Burrows RF
Arch Intern Med; 1997 Jul; 157(14):1522-30. PubMed ID: 9236553
[TBL] [Abstract][Full Text] [Related]
31. What's new in hormone replacement therapy: focus on transdermal estradiol and micronized progesterone.
Simon JA
Climacteric; 2012 Apr; 15 Suppl 1():3-10. PubMed ID: 22432810
[TBL] [Abstract][Full Text] [Related]
32. Hormones and breast cancer: evidence and implications for consideration of risks and benefits of hormone replacement therapy.
Colditz GA
J Womens Health; 1999 Apr; 8(3):347-57. PubMed ID: 10326989
[TBL] [Abstract][Full Text] [Related]
33. Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET).
Høibraaten E; Qvigstad E; Arnesen H; Larsen S; Wickstrøm E; Sandset PM
Thromb Haemost; 2000 Dec; 84(6):961-7. PubMed ID: 11154141
[TBL] [Abstract][Full Text] [Related]
34. Recent epidemiological evidence relevant to the clinical management of the menopause.
Shapiro S
Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
[TBL] [Abstract][Full Text] [Related]
35. Use of hormone replacement therapy in Washington State: is prevention being put into practice?
Saver BG; Taylor TR; Woods NF
J Fam Pract; 1999 May; 48(5):364-71. PubMed ID: 10334613
[TBL] [Abstract][Full Text] [Related]
36. HRT and the risk of deep vein thrombosis.
Barlow DH
Int J Gynaecol Obstet; 1997 Oct; 59 Suppl 1():S29-33. PubMed ID: 9386213
[TBL] [Abstract][Full Text] [Related]
37. Hormone Replacement Therapy for Primary and Secondary Prevention of Heart Disease.
Shah SH; Alexander KP
Curr Treat Options Cardiovasc Med; 2003 Feb; 5(1):25-33. PubMed ID: 12686016
[TBL] [Abstract][Full Text] [Related]
38. Opinion survey towards hormone replacement therapy in the prevention of coronary heart disease.
Rozenberg S; Fellemans C; Ham H
Maturitas; 2001 May; 38(3):273-7. PubMed ID: 11358644
[TBL] [Abstract][Full Text] [Related]
39. Design and conduct of clinical trials in hormone replacement therapy.
Holinka CF
Ann N Y Acad Sci; 2001 Sep; 943():89-108. PubMed ID: 11594562
[TBL] [Abstract][Full Text] [Related]
40. PROGESTINS IN HORMONE REPLACEMENT THERAPY: IMPACT ON ENDOMETRIAL AND BREAST CANCER.
Reid RL
J SOGC; 2000 Sep; 22(9):677-681. PubMed ID: 12457196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
